nodes	percent_of_prediction	percent_of_DWPC	metapath
Clopidogrel—CES1—Phase I biotransformations, non P450—ESD—ocular cancer	0.489	0.489	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—CDKN2C—ocular cancer	0.0308	0.0308	CbGpPWpGaD
Clopidogrel—P2RY12—Signal amplification—GNA11—ocular cancer	0.0269	0.0269	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—E2F5—ocular cancer	0.0257	0.0257	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—MYBL2—ocular cancer	0.0251	0.0251	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—E2F4—ocular cancer	0.0251	0.0251	CbGpPWpGaD
Clopidogrel—P2RY12—Signal amplification—GNAQ—ocular cancer	0.025	0.025	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—E2F2—ocular cancer	0.0247	0.0247	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—RBL1—ocular cancer	0.0247	0.0247	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—RBL2—ocular cancer	0.0226	0.0226	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—E2F3—ocular cancer	0.0214	0.0214	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—RBBP4—ocular cancer	0.0214	0.0214	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—CDC25A—ocular cancer	0.0203	0.0203	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—TFDP1—ocular cancer	0.0199	0.0199	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—CCND3—ocular cancer	0.018	0.018	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—HDAC1—ocular cancer	0.0115	0.0115	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—E2F1—ocular cancer	0.0095	0.0095	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—CDK2—ocular cancer	0.00819	0.00819	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—RB1—ocular cancer	0.00673	0.00673	CbGpPWpGaD
Clopidogrel—ABCB1—HIF-1-alpha transcription factor network—ID2—ocular cancer	0.00638	0.00638	CbGpPWpGaD
Clopidogrel—CES1—Fluoropyrimidine Activity—TP53—ocular cancer	0.00622	0.00622	CbGpPWpGaD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.00559	0.00559	CbGpPWpGaD
Clopidogrel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—ocular cancer	0.00531	0.00531	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—CDKN1B—ocular cancer	0.00524	0.00524	CbGpPWpGaD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	0.0052	0.0052	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—CDKN1A—ocular cancer	0.00484	0.00484	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—EP300—ocular cancer	0.0046	0.0046	CbGpPWpGaD
Clopidogrel—CES1—E2F transcription factor network—MYC—ocular cancer	0.00401	0.00401	CbGpPWpGaD
Clopidogrel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—ocular cancer	0.00395	0.00395	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—GNA11—ocular cancer	0.00288	0.00288	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—GNAQ—ocular cancer	0.00268	0.00268	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00249	0.00249	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.00245	0.00245	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—HDAC1—ocular cancer	0.00241	0.00241	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	0.00235	0.00235	CbGpPWpGaD
Clopidogrel—CES1—NRF2 pathway—TGFB1—ocular cancer	0.0023	0.0023	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—SAG—ocular cancer	0.00206	0.00206	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	0.00203	0.00203	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—GNA11—ocular cancer	0.00182	0.00182	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—E2F5—ocular cancer	0.00182	0.00182	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—E2F4—ocular cancer	0.00178	0.00178	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—RBL1—ocular cancer	0.00175	0.00175	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—CDK2—ocular cancer	0.00171	0.00171	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—GNAQ—ocular cancer	0.00169	0.00169	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.00167	0.00167	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—GNA11—ocular cancer	0.00165	0.00165	CbGpPWpGaD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.00162	0.00162	CbGpPWpGaD
Clopidogrel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.00154	0.00154	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—GNAQ—ocular cancer	0.00154	0.00154	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—E2F3—ocular cancer	0.00152	0.00152	CbGpPWpGaD
Clopidogrel—CYP1A2—Tryptophan metabolism—MDM2—ocular cancer	0.00142	0.00142	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TFDP1—ocular cancer	0.00141	0.00141	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	0.0013	0.0013	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.0013	0.0013	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.0012	0.0012	CbGpPWpGaD
Clopidogrel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.00118	0.00118	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.00114	0.00114	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.00114	0.00114	CbGpPWpGaD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.00113	0.00113	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MAML2—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Clopidogrel—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.0011	0.0011	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PSPH—ocular cancer	0.00109	0.00109	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PSPH—ocular cancer	0.00107	0.00107	CbGpPWpGaD
Clopidogrel—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.00107	0.00107	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00103	0.00103	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.000992	0.000992	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.000989	0.000989	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—GNA11—ocular cancer	0.000977	0.000977	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—EP300—ocular cancer	0.000963	0.000963	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000942	0.000942	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PSPH—ocular cancer	0.000927	0.000927	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—GNAQ—ocular cancer	0.000908	0.000908	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—TGFB1—ocular cancer	0.000837	0.000837	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PSPH—ocular cancer	0.000827	0.000827	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—HDAC1—ocular cancer	0.000819	0.000819	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000813	0.000813	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PSPH—ocular cancer	0.000807	0.000807	CbGpPWpGaD
Clopidogrel—ABCB1—Allograft Rejection—TGFB1—ocular cancer	0.000804	0.000804	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.000779	0.000779	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000768	0.000768	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PSPH—ocular cancer	0.000754	0.000754	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CDKN2B—ocular cancer	0.000734	0.000734	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—TP53—ocular cancer	0.000689	0.000689	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—E2F1—ocular cancer	0.000674	0.000674	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—HRAS—ocular cancer	0.000659	0.000659	CbGpPWpGaD
Clopidogrel—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000645	0.000645	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PSPH—ocular cancer	0.000645	0.000645	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—AKT1—ocular cancer	0.000582	0.000582	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000569	0.000569	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.00052	0.00052	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PSPH—ocular cancer	0.000497	0.000497	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000496	0.000496	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.00048	0.00048	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000456	0.000456	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MDM2—ocular cancer	0.000407	0.000407	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000398	0.000398	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000397	0.000397	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—HRAS—ocular cancer	0.000378	0.000378	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CDKN1B—ocular cancer	0.000372	0.000372	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—AKT1—ocular cancer	0.000368	0.000368	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CCND1—ocular cancer	0.000355	0.000355	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GNA11—ocular cancer	0.000345	0.000345	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CDKN1A—ocular cancer	0.000343	0.000343	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GNA11—ocular cancer	0.000337	0.000337	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—AKT1—ocular cancer	0.000334	0.000334	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000327	0.000327	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—EP300—ocular cancer	0.000326	0.000326	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GNAQ—ocular cancer	0.00032	0.00032	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GNAQ—ocular cancer	0.000313	0.000313	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GNA11—ocular cancer	0.000292	0.000292	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MYC—ocular cancer	0.000284	0.000284	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TGFB1—ocular cancer	0.000284	0.000284	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000276	0.000276	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GNAQ—ocular cancer	0.000271	0.000271	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GNA11—ocular cancer	0.00026	0.00026	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GNA11—ocular cancer	0.000254	0.000254	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GNAQ—ocular cancer	0.000242	0.000242	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GNA11—ocular cancer	0.000237	0.000237	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GNAQ—ocular cancer	0.000236	0.000236	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TP53—ocular cancer	0.000234	0.000234	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—HRAS—ocular cancer	0.000223	0.000223	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GNAQ—ocular cancer	0.000221	0.000221	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000219	0.000219	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GNA11—ocular cancer	0.000203	0.000203	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—AKT1—ocular cancer	0.000197	0.000197	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000195	0.000195	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GNAQ—ocular cancer	0.000189	0.000189	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000178	0.000178	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GNA11—ocular cancer	0.000157	0.000157	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000152	0.000152	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GNAQ—ocular cancer	0.000146	0.000146	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—EP300—ocular cancer	0.000115	0.000115	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—EP300—ocular cancer	0.000113	0.000113	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—EP300—ocular cancer	9.74e-05	9.74e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—EP300—ocular cancer	8.7e-05	8.7e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—EP300—ocular cancer	8.49e-05	8.49e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—EP300—ocular cancer	7.93e-05	7.93e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—AKT1—ocular cancer	6.96e-05	6.96e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—AKT1—ocular cancer	6.8e-05	6.8e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—EP300—ocular cancer	6.78e-05	6.78e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—AKT1—ocular cancer	5.89e-05	5.89e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—AKT1—ocular cancer	5.26e-05	5.26e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—EP300—ocular cancer	5.23e-05	5.23e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—AKT1—ocular cancer	5.13e-05	5.13e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—AKT1—ocular cancer	4.79e-05	4.79e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—AKT1—ocular cancer	4.1e-05	4.1e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—AKT1—ocular cancer	3.16e-05	3.16e-05	CbGpPWpGaD
